The behavioural responses to 8-OH-DPAT, ipsapirone and the novel 5-HT1A receptor agonist Bay Vq 7813 in the pig
- PMID: 2149168
- DOI: 10.1007/BF00169437
The behavioural responses to 8-OH-DPAT, ipsapirone and the novel 5-HT1A receptor agonist Bay Vq 7813 in the pig
Abstract
In pigs, behavioural responses were examined after administration of 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT), a full agonist at 5-hydroxytryptamine (5-HT) receptors of the 5-HT1A subtype, and the pyrimidinylpiperazine derivatives ipsapirone and Bay Vq 7813 (2-[4-(2-pyrimidinyl)-1-piperazinylpropyl]-1,2-benzisothiazol++ +-3(2H) one-1,1-dioxide), which act as partial agonists at 5-HT1A receptors. The most prominent behavioural response examined after 8-OH-DPAT, 0.5 mg/kg i.m., ipsapirone, 2-5 mg/kg i.m., and Bay Vq 7813, 0.5-2 mg/kg i.m. or i.v., were head shakes. The potency of the three drugs to induce this behaviour correlated with their activity at 5-HT1A receptors as determined by inhibition of forskolin-stimulated adenylate cyclase, substantiating that the head shake response has potential as a quantitative probe of in vivo receptor function. The 5-HT2/5-HT1C receptor antagonist ritanserin did not counteract the head shakes induced by ipsapirone, suggesting that neither 5-HT2 nor 5-HT1C receptors are involved in mediation of this response to this 5-HT1A receptor agonist in pigs. Once daily administration of Bay Vq 7813 or ipsapirone for 3-5 days led to a reduction in the head shake response. 1-Pyrimidinylpiperazine (1-PP), a pharmacologically active metabolite shared by ipsapirone, Bay Vq 7813, and related pyrimidinylpiperazine derivatives, did not induce behavioural alterations in pigs. The data provide further evidence that marked species differences exist in functional responses to 5-HT receptor ligands.
Similar articles
-
Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.J Pharmacol Exp Ther. 1998 Mar;284(3):1082-94. J Pharmacol Exp Ther. 1998. PMID: 9495870
-
Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.Br J Pharmacol. 1990 Nov;101(3):667-73. doi: 10.1111/j.1476-5381.1990.tb14138.x. Br J Pharmacol. 1990. PMID: 2150180 Free PMC article.
-
Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.Mol Pharmacol. 1990 Feb;37(2):231-7. Mol Pharmacol. 1990. PMID: 1968223
-
5-HT1A receptor influences on rodent social and agonistic behavior: a review and empirical study.Neurosci Biobehav Rev. 1994 Fall;18(3):325-38. doi: 10.1016/0149-7634(94)90046-9. Neurosci Biobehav Rev. 1994. PMID: 7984351 Review.
-
Classification of opioid and 5-hydroxytryptamine receptors by means of discriminative drug effects.Neuropharmacology. 1987 Jul;26(7B):867-75. doi: 10.1016/0028-3908(87)90064-5. Neuropharmacology. 1987. PMID: 2821430 Review.
Cited by
-
Effects of the 5-HT2 receptor antagonist ritanserin on halothane-induced increase of inositol phosphates in porcine malignant hyperthermia.Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):593-7. doi: 10.1007/BF00170833. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8938657
-
The effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pig.Br J Pharmacol. 1994 Jul;112(3):861-6. doi: 10.1111/j.1476-5381.1994.tb13159.x. Br J Pharmacol. 1994. PMID: 7921613 Free PMC article.
-
Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):365-74. doi: 10.1007/BF00178953. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7845474
References
MeSH terms
Substances
LinkOut - more resources
Miscellaneous